These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28231522)

  • 21. Studies on the mechanism of antimalarial action of a novel arylene bis(methylketone).
    Berger BJ; Dai WW; Cerami A; Ulrich P
    Biochem Pharmacol; 1997 Sep; 54(6):739-42. PubMed ID: 9310351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
    Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
    Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
    J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
    Graffner-Nordberg M; Fyfe M; Brattsand R; Mellgård B; Hallberg A
    J Med Chem; 2003 Jul; 46(16):3455-62. PubMed ID: 12877583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of febrifugine derivatives and development of an effective and safe tetrahydroquinazoline-type antimalarial.
    Kikuchi H; Horoiwa S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
    Eur J Med Chem; 2014 Apr; 76():10-9. PubMed ID: 24565569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bhagat S; Arfeen M; Bhatia S; Sirawaraporn R; Sirawaraporn W; Chakraborti AK; Bharatam PV
    Bioorg Med Chem Lett; 2014 Jan; 24(2):613-7. PubMed ID: 24361001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
    Elslager EF; Hutt MP; Jacob P; Johnson J; Temporelli B; Werbel LM; Worth DF; Rane L
    J Med Chem; 1979 Oct; 22(10):1247-57. PubMed ID: 117107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
    Thakkar SS; Thakor P; Doshi H; Ray A
    Bioorg Med Chem; 2017 Aug; 25(15):4064-4075. PubMed ID: 28634040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
    Nduati E; Hunt S; Kamau EM; Nzila A
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate antagonists. 9. 2,4-Diamino-6-((aralkyl)alkylamino)quinazolines, a potent class of antimetabolites with prodigious antimalarial effects.
    Elslager EF; Bird OD; Clarke J; Perricone SC; Worth DF
    J Med Chem; 1972 Nov; 15(11):1138-46. PubMed ID: 4631920
    [No Abstract]   [Full Text] [Related]  

  • 34. Looking for new antiplasmodial quinazolines: DMAP-catalyzed synthesis of 4-benzyloxy- and 4-aryloxy-2-trichloromethylquinazolines and their in vitro evaluation toward Plasmodium falciparum.
    Gellis A; Primas N; Hutter S; Lanzada G; Remusat V; Verhaeghe P; Vanelle P; Azas N
    Eur J Med Chem; 2016 Aug; 119():34-44. PubMed ID: 27155463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum.
    Sirichaiwat C; Intaraudom C; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y
    J Med Chem; 2004 Jan; 47(2):345-54. PubMed ID: 14711307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.
    Zhang Z; Wu J; Ran F; Guo Y; Tian R; Zhou S; Wang X; Liu Z; Zhang L; Cui J; Liu J
    Eur J Med Chem; 2009 Feb; 44(2):764-71. PubMed ID: 18555562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Kettler K; Wiesner J; Fucik K; Sakowski J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
    Pharmazie; 2005 Sep; 60(9):677-82. PubMed ID: 16222868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001-2021).
    Bhagat K; Kumar N; Kaur Gulati H; Sharma A; Kaur A; Singh JV; Singh H; Bedi PMS
    Expert Opin Ther Pat; 2022 Oct; 32(10):1079-1095. PubMed ID: 36189616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
    Nzila A
    Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.